RMRobert N. Muller

Robert N. Muller

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert N. Muller has a total of 121 co-authors. Here are the top co-authors by number of shared publications:

  • Luce Vander Elst

    Department of General Organic and Biomedical Chemistry, University of Mons, Place du Parc 23, 7000 Mons (Belgium)

    28 shared publications
  • Sophie Laurent

    UMONS Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory B‐7000 Mons Belgium

    24 shared publications
  • Sophie Laurent

    Laboratory of NMR and Molecular Imaging, Department of General, Organic and Biomedical Chemistry, University of Mons, B-7000 Mons, Belgium

    13 shared publications
  • Dimitri Stanicki

    Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons (UMONS), 7000 Mons, Belgium

    5 shared publications
  • François Botteman

    NMR and Molecular Imaging Laboratory, Department ofGeneral, Organic and Biomedical Chemistry, University of Mons-Hainaut, 7000 Mons, Belgium, Fax: +32-65-373520

    5 shared publications
  • Alain Roch

    Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons-Hainaut, 24 Avenue du Champ de Mars, B-7000 Mons, Belgium, Biological Physics Department, University of Mons-Hainaut, 24 Avenue du Champ de Mars, B-7000 Mons, Belgium, and Laboratory of Inorganic and Analytic Chemistry, University of Mons-Hainaut, 24 Avenue du Champ de Mars, B-7000 Mons, Belgium

    4 shared publications

Latest Publications

  • Molecular Imaging and Contrast Agents

    by Dimitri Stanicki, Lionel Larbanoix, Sébastien Boutry, Robert N. Muller, Sophie Laurent

  • Open Access

    Front Cover: Bimodal Probe for Magnetic Resonance Imaging and Photoacoustic Imaging Based on a PCTA‐Derived Gadolinium(III) Complex and ZW800–1 (Eur. J. Inorg. Chem. 29/2019)

    by Marie Devreux, Céline Henoumont, Fabienne Dioury, Dimitri Stanicki, Sébastien Boutry, Lionel Larbanoix, Clotilde Ferroud, Robert N. Muller, Sophie Laurent


  • Bimodal Probe for Magnetic Resonance Imaging and Photoacoustic Imaging Based on a PCTA‐Derived Gadolinium(III) Complex and ZW800–1

    by Marie Devreux, Céline Henoumont, Fabienne Dioury, Dimitri Stanicki, Sébastien Boutry, Lionel Larbanoix, Clotilde Ferroud, Robert N. Muller, Sophie Laurent

    Invited for the cover of this issue is the group of Sophie Laurent from the University of Mons, Belgium. The cover image shows a blood vessel containing the bimodal probe reported in this paper.


  • Bimodal Probe for Magnetic Resonance Imaging and Photoacoustic Imaging Based on a PCTA‐Derived Gadolinium(III) Complex and ZW800–1

    by Marie Devreux, Céline Henoumont, Fabienne Dioury, Dimitri Stanicki, Sébastien Boutry, Lionel Larbanoix, Clotilde Ferroud, Robert N. Muller, Sophie Laurent

    One of the most widely used techniques to obtain anatomical information is magnetic resonance imaging (MRI). Despite its high resolution, it has a low sensitivity which could be enhanced by coupling MRI with a more sensitive technique such as photoacoustic imaging (PAI). The development of a bimodal agent could thus lead to hybrid images with a high anatomical resolution provided by MRI and a precise localization of the contrast agent thanks to PAI. The probes used in this work are a gadolinium(III) complex derived from PCTA‐[12] for MRI and the ZW800–1 fluorophore for PAI. These two organic parts have been attached to a L‐lysine derivative which has a third site for potential conjugation to a biovector, thus opening the field of targeted probes for molecular imaging. Preliminary relaxometric and photoacoustic characterizations indicate that this bimodal agent is a promising compound for bimodal imaging.


  • Evaluation of the Active Targeting of Melanin Granules after Intravenous Injection of Dendronized Nanoparticles

    by Catalina Bordeianu, Audrey Parat, Sébastien Piant, Aurélie Walter, Christine Zbaraszczuk-Affolter, Florent Meyer, Sylvie Begin-Colin, Sébastien Boutry, Robert N. Muller, Elodie Jouberton, et al.

    The biodistribution of dendronized iron oxides, NPs10@D1_DOTAGA and melanin-targeting NPs10@D1_ICF_DOTAGA, was studied in vivo using MRI and planar scintigraphy through [177Lu]Lu-radiolabeling. MRI experiments showed high contrast power of both dendronized nanoparticles (DPs) and hepatobiliary and urinary excretions. Little tumor uptake could be highlighted after intravenous injection probably as a consequence of the negatively charged DOTAGA-derivatized shell which reduces the diffusion across the cells’ membrane. Planar scintigraphy images demonstrated a moderate specific tumor uptake of melanoma-targeted [177Lu]Lu-NPs10@D1_ICF_DOTAGA at 2 h post intravenous injection, and the highest tumor uptake of the control probe [177Lu]Lu-NPs10@D1_DOTAGA at 30min pi, probably due to the enhanced permeability and retention (EPR) effect. In addition, ex vivo Confocal microscopy (EVCM) studies showed a high specific targeting of human melanoma samples impregnated with NPs10@D1_ICF_Alexa647_ DOTAGA.


  • Open Access

    610. An Inducible AAV Vector Mediating GDNF Signal Transduction at Clinically-Acceptable Sub-Antimicrobial Doxycycline Doses

    by Liliane Tenenbaum, Abdelwahed Chtarto, Marie Humbert-Claude, Olivier Bockstael, Atze T. Das, Sébastien Boutry, Ludivine Breger, Bep Claver, Robert N. Müller, Olivier De Witte, et al.

  • Terpyridine-Based Heteroditopic Ligand for RuIILn3III Metallostar Architectures (Ln = Gd, Eu, Nd, Yb) with MRI/Optical or Dual-Optical Responses

    by Alexandre Boulay, Céline Deraeve, Luce Vander Elst, Nadine Leygue, Olivier Maury, Sophie Laurent, Robert N. Muller, Béatrice Mestre-Voegtlé, Claude Picard

    A new ditopic ligand (L) based on a 2,2′:5′,4″-terpyridine unit substituted in the 2″,6″ positions with iminodiacetate arms has been designed and synthesized for the construction of RuIIL3Ln3III supramolecular architectures. The two components of this system, a 2,2′-bipyridine unit for RuII coordination and a pyridine-bis(iminodiacetate) core for LnIII coordination, are tightly connected via a covalent Carom(py)–Carom(py) bond. The paramagnetic and photophysical properties of the corresponding tetrametallic RuIIL3Gd3III complex have been evaluated, highlighting the potential of this metallostar structure to act as a bimodal MRI/optical imaging agent. Variable-temperature 17O NMR and proton nuclear magnetic relaxation dispersion (NMRD) measurements showed that this complex exhibits (i) a remarkable relaxivity per metallostar molecule, particularly at clinical and high magnetic fields (r1310K = 51.0 and 36.0 mM–1 s–1 at 20 and 300 MHz, respectively) and (ii) a near-optimal residence lifetime of GdIII coordinated water molecule (τM310K = 77.5 ns). This is the result of the presence of two inner-sphere water molecules in the GdIII components of the metallostar and a slow tumbling rate of the molecule (τR310K = 252 ps). Upon excitation in the visible domain (λexc = 472 nm), the RuII component of the complex exhibits a bright-red luminescence centered at 660 nm with a quantum yield of 2.6% in aqueous solutions at pH 7.4. Moreover, this RuIIL3Gd3III assembly is also characterized by a high kinetic inertness in biological media (PBS and human serum solutions) and a high photostability (photobleaching). Finally, preliminary photophysical studies on RuL3Nd3 and RuL3Yb3 assemblies revealed that the RuII center acts as an effective sensitizer for LnIII-based luminescence in the near-IR region. The NdIII species was found to be the most effective at quenching the 3MLCT luminescence of the Ru center.


  • New carboxysilane‐coated iron oxide nanoparticles for nonspecific cell labelling

    by Jean‐Luc Bridot, Dimitri Stanicki, Sophie Laurent, Sébastien Boutry, Yves Gossuin, Philippe Leclère, Roberto Lazzaroni, Luce Vander Elst, Robert N. Muller

    Magnetic resonance imaging (MRI) offers the possibility of tracking cells labelled with a contrast agent and evaluating the progress of cell therapies. This requires efficient cell labelling with contrast agents. A basic incubation of cells with iron oxide nanoparticles (NPs) is a common method. This study reports the synthesis at the gram scale of iron oxide nanoparticles as MRI T₂ contrast agents for cell labelling. These NPs are based on small iron oxide cores coated with a thin polysiloxane shell presenting carboxylic acid functions. The iron oxide cores produced have been characterized by transmission electron microscopy, X-ray diffraction, ζ-potential, infrared, photon correlation spectroscopy, atomic force microscopy, magnetometry and relaxometric measurements. These measurements confirmed the expected surface modification by carboxysilane. Carboxylic groups created electrostatic repulsion between NPs when they are deprotonated. Therefore, highly concentrated aqueous solutions of carboxysilane coated iron oxide NPs can be obtained, up to 70% (w/w). These NPs could be used for cell labelling owing to their aggregation and re-dispersion properties. NPs precipitated in Dulbecco's modified Eagle medium induced a rapid association with 3 T6 fibroblast cells and could easily be re-dispersed in phosphate buffer saline solution to obtain properly labelled cells.


  • Dysprosium Complexes and Their Micelles as Potential Bimodal Agents for Magnetic Resonance and Optical Imaging

    by Elke Debroye, Sophie Laurent, Luce Vander Elst, Robert N. Muller, Tatjana N. Parac-Vogt

    Six diethylene triamine pentaacetic acid (DTPA) bisamide derivatives functionalized with p‐toluidine (DTPA‐BTolA), 6‐aminocoumarin (DTPA‐BCoumA), 1‐naphthalene methylamine (DTPA‐BNaphA), 4‐ethynylaniline (DTPA‐BEthA), p‐dodecylaniline (DTPA‐BC12PheA) and p‐tetradecyl‐aniline (DTPA‐BC14PheA) were coordinated to dysprosium(III) and the magnetic and optical properties of the complexes were examined in detail. The complexes consisting of amphiphilic ligands (DTPA‐BC12PheA and DTPA‐BC14PheA) were further assembled into mixed micelles. Upon excitation into the ligand levels, the complexes display characteristic DyIII emission with quantum yields of 0.3–0.5 % despite the presence of one water molecule in the first coordination sphere. A deeper insight into the energy‐transfer processes has been obtained by studying the photophysical properties of the corresponding GdIII complexes. Since the luminescence quenching effect is decreased by the intervention of non‐ionic surfactant, quantum yields up to 1 % are obtained for the micelles. The transverse relaxivity r2 per DyIII ion at 500 MHz and 310 K reaches a maximum value of 27.4 s−1 mM−1 for Dy‐DTPA‐BEthA and 36.0 s−1 mM−1 for the Dy‐DTPA‐BC12PheA assemblies compared with a value of 0.8 s−1 mM−1 for Dy‐DTPA. The efficient T2 relaxation, especially at high magnetic field strengths, is sustained by the high magnetic moment of the dysprosium ion, the coordination of water molecules with slow water exchange kinetics and long rotational correlation times. These findings open the way to the further development of bimodal optical and magnetic resonance imaging probes starting from single lanthanide compounds.